Bioventus BVS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Net Sales by Business | ||||||
| International Segment | $68.28M+3.5% | $65.99M0.0% | $66.01M-1.1% | $66.73M+3.2% | $64.65M-2.7% | |
| U.S. Segment | $508.02M+1.2% | $502.1M+0.9% | $497.82M+0.1% | $497.41M-1.1% | $503.05M-0.7% | |
| Total Net Sales by Product | ||||||
| Pain Treatments | $283.57M+1.6% | $279.06M+3.9% | $268.62M+1.5% | $264.57M+0.4% | $263.52M+0.9% | |
| Restorative Therapies | $86.29M+1.1% | $85.37M-8.6% | $93.37M-8.5% | $102M-8.9% | $111.99M-8.8% | |
| Surgical Solutions | $206.45M+1.4% | $203.65M+0.9% | $201.84M+2.2% | $197.57M+2.8% | $192.2M+1.6% | |
| Total Net Sales by Geography | ||||||
| International | $68.28M+3.5% | $65.99M0.0% | $66.01M-1.1% | $66.73M+3.2% | $64.65M-2.7% | |
| U.S. | $508.02M+1.2% | $502.1M+0.9% | $497.82M+0.1% | $497.41M-1.1% | $503.05M-0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bioventus break its business down?
- Bioventus (BVS) reports total net sales by business across 2 parts — International Segment and U.S. Segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Bioventus's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bioventus's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
